Toshitaka Yajima, MD, PhD, has received a 5-year, nearly $2 million R01 grant award from the National Heart, Lung, and Blood Institute (NHLBI) for his cardiology research.
Dr. Yajima investigates the heart’s natural defenses against viral infections and other agents of cardiac injury.
“The goal of this project,” Dr. Yajima said, “is to determine unidentified crosstalk between innate immune and cardioprotective mechanisms that converge on mitochondria by focusing on molecular and signaling mechanisms mediated through mitochondria antiviral signaling (MAVS).” | Read the abstract of Dr. Yajima’s grant
His long-term goal is to uncover new treatment avenues for cardiac diseases such as virus-mediated cardiomyopathy, dilated cardiomyopathy, ischemic heart disease and toxic cardiomyopathy.
Dr. Yajima, Assistant Professor of Medicine, joined the Division of Cardiology faculty in 2009.